Carrara V, Porchet H, Dayer P
Division of Clinical Pharmacology, University Hospital, Geneva, Switzerland.
Eur J Clin Pharmacol. 1994;46(1):29-33. doi: 10.1007/BF00195912.
Since the magnitude of the response to a drug may depend upon the drug input rate, the concentration-effect relationship of the new dihydropyridine (+/-)-isradipine was investigated using different administration modalities. Ten normotensive healthy volunteers were given, double-blind and in a crossover fashion, isradipine as a 1 mg iv infusion, 5 mg oral solution, 5 mg standard tablet, 10 mg slow release formulation, and a placebo. Blood pressure, heart rate, and plasma isradipine concentrations were recorded for 24 h. The maximal fall in diastolic blood pressure was similar after the infusion (-11.40 mmHg), the oral solution (-15.20 mmHg), and the standard tablet (-12.50 mmHg). In healthy volunteers the slow release form had no significant effect on blood pressure. The concentration-effect plots showed an increasing slope in the order infusion, solution, and table, and anticlockwise hysteresis. This was partly due to marked heart rate counter-regulation, the corresponding mean maximal heart rate increases being 24, 19, and 17 beats.min-1. The pronounced counter-regulation of the heart rate implies that a slow isradipine input rate would be more effective in decreasing blood pressure.
由于对药物反应的强度可能取决于药物输入速率,因此使用不同给药方式研究了新型二氢吡啶(±)-伊拉地平的浓度-效应关系。10名血压正常的健康志愿者以双盲交叉方式接受伊拉地平,分别为1mg静脉输注、5mg口服溶液、5mg标准片剂、10mg缓释制剂以及安慰剂。记录24小时的血压、心率和血浆伊拉地平浓度。输注后(-11.40mmHg)、口服溶液后(-15.20mmHg)和标准片剂后(-12.50mmHg)舒张压的最大降幅相似。在健康志愿者中,缓释剂型对血压无显著影响。浓度-效应图显示输注、溶液和片剂的斜率依次增加,且呈逆时针滞后。这部分是由于明显的心率反向调节,相应的平均最大心率增加分别为24、19和17次·分钟-1。心率的明显反向调节意味着伊拉地平的缓慢输入速率在降低血压方面可能更有效。